{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:51:14Z","timestamp":1784807474654,"version":"3.55.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:p>This secondary analysis of a randomized clinical trial describes the use of emergency care after self-administration of etripamil by patients experiencing paroxysmal supraventricular tachycardia episodes at home.<\/jats:p>","DOI":"10.1001\/jamacardio.2025.0417","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:00:46Z","timestamp":1744210846000},"page":"632","source":"Crossref","is-referenced-by-count":4,"title":["Self-Administered Etripamil and Emergency Department Visits in Supraventricular Tachycardia"],"prefix":"10.1001","volume":"10","author":[{"given":"Sean D.","family":"Pokorney","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Camm","sequence":"additional","affiliation":[{"name":"St George\u2019s University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dorian","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Ip","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine, New York Presbyterian Hospital, New York City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"Stambler","sequence":"additional","affiliation":[{"name":"Piedmont Healthcare, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Bharucha","sequence":"additional","affiliation":[{"name":"Milestone Pharmaceuticals, Inc, Charlotte, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"hld250002r1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S0735-1097(00)01128-1","article-title":"Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.","volume":"37","author":"Alboni","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"10396","key":"hld250002r2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0140-6736(23)00776-6","article-title":"Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial.","volume":"402","author":"Stambler","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"hld250002r3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.010915","article-title":"The first randomized, multicenter, placebo-controlled study of self-administered intranasal etripamil for acute conversion of spontaneous paroxysmal supraventricular tachycardia (NODE-301).","volume":"15","author":"Stambler","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"hld250002r4","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jval.2023.03.216","article-title":"CO143 Impact of investigational at-home, self-administered, intranasal etripamil on the need for additional medical intervention in patients with supraventricular tachycardia.","volume":"26","author":"Pokorney","year":"2023","journal-title":"Value Health"},{"issue":"8","key":"hld250002r5","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1111\/jce.15109","article-title":"Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in the United States.","volume":"32","author":"Rehorn","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"hld250002r6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ahj.2020.12.012","article-title":"Trends in health care resource use and expenditures in patients with newly diagnosed paroxysmal supraventricular tachycardia in the United States.","volume":"233","author":"Chew","year":"2021","journal-title":"Am Heart J"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2832045\/jamacardiology_pokorney_2025_ld_250002_1749063420.10282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:01:01Z","timestamp":1749654061000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2832045"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2025.0417","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}